FDA Inspection 1325808 — Dr. Muhammad Imran, M.D.
The FDA completed an inspection of Dr. Muhammad Imran, M.D. on June 12, 2026 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 12, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Clinical BA/BE